Note 3 - Net Loss Per Share

3 Months Ended

Mar. 31, 2017

Notes to Financial Statements

Earnings Per Share [Text Block]

Note

3.

Net Loss Per Share

Our basic net loss per share attributable to Progenics amounts have been computed by dividing net loss attributable to Progenics by the weighted-average number of common shares outstanding during the period. For the

three

months ended

March

31,

2017

and

2016,

we reported net losses and, accordingly, potential common shares were not included since such inclusion would have been anti-dilutive.

The calculations of net loss per share, basic and diluted, are as follows (amounts in thousands, except per share data):

	Net loss			Weighted-average
	attributable			shares
	to Progenics			outstanding		Per share
	(Numerator)			(Denominator)		amount
Three months ended March 31, 2017
Basic and diluted	$	(16,360	)		70,196	$	(0.23	)
Three months ended March 31, 2016
Basic and diluted	$	(12,655	)		69,946	$	(0.18	)

The following table summarizes anti-dilutive common shares or common shares where performance conditions have not been met, that were excluded from the calculation of diluted net loss per share (in thousands):

	Three Months Ended March 31,
	2017		2016
Stock options		1,150		5,411
Contingent consideration liability		1,706		4,267
Total securities excluded		2,856		9,678